Search results
Advanced RNA Sequencing Reveals the Drivers of New COVID Variants
SciTechDaily· 6 days agoThe SARS-CoV-2 virus that causes COVID has the unsettling ability of often generating variants of...
Bird flu virus has been spreading in US cows for months, RNA reveals
Nature· 1 day agoGenomic analysis suggests that the outbreak probably began in December or January, but a shortage of...
Kinetics of Hepatitis E Virus Infections in Asymptomatic Persons
Centers for Disease Control and Prevention· 1 day agoHepatitis E virus (HEV; family Hepeviridae), is a single-stranded positive-sense RNA virus with 3 open reading frames (1). Although infections with HEV-1 and HEV-2 are endemic ...
Cows' milk particles used for effective oral delivery of drugs
Phys.org· 3 days agoRibonucleic acid (RNA) therapies are a powerful new class of drugs that offer a way to target...
Ipsen, Skyhawk to develop RNA-targeting pills for rare brain diseases
BioPharma Dive via Yahoo Finance· 6 days agoDive Brief: French pharmaceutical company Ipsen will work with privately held biotechnology company...
RNA Modification Behind Disruption of Mitochondrial Protein Synthesis in Alzheimer’s
Technology Networks· 2 days agoA team of researchers at Johannes Gutenberg University Mainz (JGU) has identified a mechanism that...
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yucaipa News Mirror· 5 days agoAvidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide ...
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
Morningstar· 5 days ago...Netherlands & CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced it will present new preclinical data for its proprietary Axiomer™ RNA editing technology...
Bristol Myers Squibb closes immuno-oncology, cell therapy-focused Redwood City site
FierceBiotech· 2 days agoOne of Chris Boerner’s first tours as the new CEO of Bristol Myers Squibb was of a 256,000...
Could a Novel RNA-Based Vaccine Strategy Stop Endless Boosters?
Technology Networks· 6 days agoEach year, seasonal influenza vaccines are designed to protect against the four main types of flu...